FDA 21 CFR Part 11 vs IEC 62443
FDA 21 CFR Part 11
FDA regulation for electronic records signatures equivalency
IEC 62443
International standard for IACS cybersecurity frameworks.
Quick Verdict
FDA 21 CFR Part 11 ensures electronic records' trustworthiness for life sciences compliance, while IEC 62443 provides cybersecurity framework for industrial control systems. Companies adopt Part 11 for FDA enforcement; IEC 62443 for OT risk management and certification.
FDA 21 CFR Part 11
21 CFR Part 11 Electronic Records; Electronic Signatures
Key Features
- Establishes equivalency for electronic records to paper
- Mandates secure time-stamped audit trails
- Differentiates controls for closed open systems
- Requires unique non-repudiable electronic signatures
- Applies risk-based predicate rule reliance scope
IEC 62443
IEC 62443: IACS Security Standards Series
Key Features
- Zones and conduits risk-based segmentation model
- Security Levels SL-T, SL-C, SL-A triad
- Shared responsibility across asset owners, suppliers, integrators
- Seven Foundational Requirements FR1-7 for systems/components
- ISASecure modular certifications SDLA, CSA, SSA
Detailed Analysis
A comprehensive look at the specific requirements, scope, and impact of each standard.
FDA 21 CFR Part 11 Details
What It Is
21 CFR Part 11 is a US FDA regulation defining criteria under which electronic records and electronic signatures are trustworthy, reliable, and equivalent to paper records and handwritten signatures. It targets FDA-regulated industries maintaining predicate-rule records electronically. Adopts a risk-based approach with narrow scope and enforcement discretion per 2003 guidance.
Key Components
- Closed systems (§11.10): validation, audit trails, access limits, operational/authority/device checks, training, policies.
- Open systems (§11.30): encryption, digital signatures added.
- Signatures (Subparts B/C): manifestation (§11.50), linking (§11.70), uniqueness (§11.100), multi-component controls (§11.200/300). Built on predicate rules; focuses enforced core controls; compliance via validation and SOPs.
Why Organizations Use It
- Meets legal obligations for pharma, devices, biologics.
- Ensures data integrity, avoids enforcement actions.
- Enables efficient paperless operations, inspection readiness.
- Builds trust, accelerates digital transformation.
Implementation Overview
Phased risk-based: scope assessment, CSV (IQ/OQ/PQ), vendor governance, training. Applies to life sciences in US; verified via FDA inspections.
IEC 62443 Details
What It Is
IEC 62443 is the international consensus-based series of standards for securing Industrial Automation and Control Systems (IACS). It provides a comprehensive, risk-based framework spanning governance, risk assessment, system architecture, and component security across the full lifecycle.
Key Components
- Four groupings: General (-1), Policies (-2), System (-3), Components (-4).
- Seven Foundational Requirements (FR1-7) like authentication, integrity, and availability.
- Zones/conduits model for segmentation; Security Levels (SL 0-4) with SL-T, SL-C, SL-A.
- ~140 component requirements; maturity levels ML1-4; ISASecure certifications (SDLA, CSA, SSA).
Why Organizations Use It
- Mitigates OT risks in critical infrastructure (energy, manufacturing).
- Enables shared responsibility among asset owners, integrators, suppliers.
- Reduces downtime, supply chain risks; supports insurance, procurement.
- Builds trust via certified assurance; horizontal applicability per IEC.
Implementation Overview
Phased: governance (2-1), risk assessment/zoning (3-2), requirements (3-3/4-2), certification. Applies to all IACS users globally; requires OT expertise, audits for maturity/certification. (178 words)
Key Differences
| Aspect | FDA 21 CFR Part 11 | IEC 62443 |
|---|---|---|
| Scope | Electronic records/signatures trustworthiness | IACS cybersecurity across lifecycle |
| Industry | FDA-regulated life sciences | Industrial automation sectors globally |
| Nature | Mandatory US FDA regulation | Voluntary international standard |
| Testing | Risk-based system validation | Security level assessments/certification |
| Penalties | Warning letters, enforcement actions | No legal penalties, certification loss |
Scope
Industry
Nature
Testing
Penalties
Frequently Asked Questions
Common questions about FDA 21 CFR Part 11 and IEC 62443
FDA 21 CFR Part 11 FAQ
IEC 62443 FAQ
You Might also be Interested in These Articles...

The 2026 Cyber Essentials Hybrid Audit Checklist: Gathering Unassailable Proof Across M365, AWS, and Azure
Build an evidence vault that passes Cyber Essentials Plus audits in 2026. Practical guidance on firewalls, secure configuration, and malware protection across M

CIS Controls v8.1 IG1 Ransomware-Resilience Sprint: A 30-60-90 Day Action Plan (With Evidence Checklist)
Tactical CIS Controls v8.1 IG1 playbook for ransomware resilience. 30-60-90 day sprint with tool-agnostic tasks, ownership & evidence checklists to prove progre

SOC 2 for Bootstrapped SaaS: Lazy Founder's Automation Roadmap with Vanta/Drata Templates
Bootstrapped SaaS founders: Achieve SOC 2 Type 2 in 3 months with Vanta automation (cuts 70% manual work). Free templates, workflows, screenshots, metrics & Sig
Run Maturity Assessments with GRADUM
Transform your compliance journey with our AI-powered assessment platform
Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.
Explore More Comparisons
See how FDA 21 CFR Part 11 and IEC 62443 compare against other standards